Cystic diseases in urology : Recommendations for patients with systemic mast cell disease
The systemic mast cell disease (MCAD; prevalence 17%) may occur frequently in urological patients. MCAD-induced changes include cysts in all organs, also in the urogenital system. In the presence of MCAD, the surgical removal of such cysts must consider specific features of the MCAD in order to redu...
Saved in:
Published in: | Urologe. Ausgabe A |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | German |
Published: |
Germany
01-10-2022
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The systemic mast cell disease (MCAD; prevalence 17%) may occur frequently in urological patients. MCAD-induced changes include cysts in all organs, also in the urogenital system. In the presence of MCAD, the surgical removal of such cysts must consider specific features of the MCAD in order to reduce surgical and complication risks. Vice versa, if in urological examinations multiple cysts are found, this could be an indication of a possibly existing, in some circumstances, unrecognized MCAD. |
---|---|
ISSN: | 1433-0563 |
DOI: | 10.1007/s00120-022-01841-4 |